I wasnt drunk enough to look this dead, I thought
00:07:21 Vickie Danaher So for instance, the new oral semaglutide for obesity is also approved to reduce the risk of cardiovascular events, such as strokes or heart attacks, in patients with cardiovascular disease and obesity
By restoring cytokine signaling, correcting T cell imbalances, and potentially reprogramming the central neuroimmune axis, Epitalon positions itself not as an immune stimulant, but as an immune homeostasis modulator
More serious but rare risks include pancreatitis, gallbladder disease, and in diabetes patients, potential worsening of diabetic retinopathy (particularly with semaglutide)
The primary reason to increase is if weight loss has plateaued or you are not losing weight on tirzepatide at your current dose
Call 904-265-4777 for your Free consultation